Literature DB >> 16183061

A comparison of four screening methods for cervical neoplasia.

SuFang Wu1, Li Meng, ShiXuan Wang, Ding Ma.   

Abstract

OBJECTIVE: To evaluate the sensitivity and accuracy of 4 screening methods for cervical neoplasia.
METHODS: Cervical samples from 450 women were evaluated for human papillomavirus DNA with a second-generation hybridization assay. Visual inspection, colposcopy, and liquid-based cytology were also performed for 273 of these women. The sensitivity, specificity, efficiency, positive predictive value (PPV), negative predictive value (NPV), Youden index, and kappa value of the different screening methods were compared.
RESULTS: Liquid-based cytology was superior in specificity (98.63%) and PPV (92.86%) to visual inspection and colposcopy, while human papillomavirus DNA testing was superior in sensitivity (88.89%) and NPV (97.10%) to visual inspection and colposcopy. The best concordance with histologic findings was achieved by using both liquid-based cytology and viral DNA hybridization.
CONCLUSION: Visual inspection and colposcopy should not be used when screening for early stage cervical lesions. The DNA hybridization assay is the best choice in primary screening, if available. Screening should begin at the age of 20 years.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183061     DOI: 10.1016/j.ijgo.2005.08.013

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  2 in total

1.  Detection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China.

Authors:  Jing Jiang; Li-Hui Wei; Ya-Li Li; Rui-Fang Wu; Xing Xie; You-Ji Feng; Guo Zhang; Chao Zhao; Yun Zhao; Zhong Chen
Journal:  J Mol Diagn       Date:  2010-09-23       Impact factor: 5.568

2.  Review on the medical and health economic evidence for an inclusion of colposcopy in primary screening programs for cervical cancer.

Authors:  Marc Nocon; Thomas Mittendorf; Stephanie Roll; Wolfgang Greiner; Stefan N Willich; Johann-Matthias von der Schulenburg
Journal:  GMS Health Technol Assess       Date:  2007-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.